Deep Neuromuscular Blockade in Strabismus Surgery
Strabismus
About this trial
This is an interventional prevention trial for Strabismus
Eligibility Criteria
Inclusion Criteria: Pediatric patients between the ages of 3 and 18 who are American Society of Anesthesiologists physical classification (ASA) I, II, or III scheduled for strabismus surgery under general anesthesia. Exclusion Criteria: Patients with underlying cardiovascular disease Patients with preoperative electrocardiograms showing conduction disturbances Patients with neuromuscular disease Any other patient who, in the opinion of the investigator, is not a good candidate for the study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
block group
control group
Maintaining moderate to deep neuromuscular blockade during an intraoperative period (Train-of-four 0-3, post-tetanic count > 1) Rocuronium (intravenous, 1.0 mg/kg)
Maintaining shallow to minimal neuromuscular blockade during an intraoperative period (Train-of-four 4, post-tetanic count < 0.9) Rocuronium (intravenous, 0.3 mg/kg)